Friday, July 10, 2020

Gilead's remdesivir reduces coronavirus mortality risk: Study


Gilead's remdesivir reduces coronavirus mortality risk: Study


Family emergency medicine physician Dr. Janette Nesheiwat applauds President Trump for securing 100 percent of remdesivir for the month of July and 90 percent for August and September since there's now a shortage of the drug.

via Industries https://ift.tt/3iOS7uU

No comments:

Post a Comment